Skip to content
★ Sign in to follow
JL
Total declarations
89
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (15 ops.)
€2.2M

Latest filing published 28 May 2024 for Tandem Diabetes Care INC.

Insider track record

Disclosed buys
0
Disclosed sells
15

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

James Leal: trading record in brief

James Leal is a declared insider of Tandem Diabetes Care Inc (senior executive), with filings sourced from SEC (Form 4). Between 28 June 2021 and 28 May 2024, the trades on record add up to 89 filings.

The open-market record consists of 15 sales worth €2.2M, with no purchase. The rest of the record consists of 33 share grants and 41 option exercises.

The latest filing, published on 28 May 2024, reports a share grant of €6,149 in Tandem Diabetes Care Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to James Leal

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations28 total

25 of 28 declarations